Harmonizing HTA Evidence Needs and Expectations: Challenges and Opportunities to Improve Evidence Generation, Ensure Access and Affordability

Documenti analoghi

• Evolving Recommendations for Patient Populations Among Oncology Medicines: A Quantitative and Qualitative Analysis
  di: Milou A. Hogervorst, et al.
  Pubblicazione: (2025)
• Questioning Conclusions and Statements on the German HTA System: A Critical Perspective
  di: Jörg Tomeczkowski, et al.
  Pubblicazione: (2024)
• Reply to: “Questioning Conclusions and Statements on the German HTA System: A Critical Perspective”
  di: James Harnett, et al.
  Pubblicazione: (2024)
• Agreement about Availability of Alternative Treatments for Innovative Drugs Assessed by the EMA and HTA Organizations
  di: Jorge Madrid Paredes, et al.
  Pubblicazione: (2024)
• Corrections to “Effectively Leveraging RWD for External Controls: A Systematic Literature Review of Regulatory and HTA Decisions”
  Pubblicazione: (2024)